Ads
related to: ptsd treatment
Search results
FDA panel rejects psychedelic drug MDMA as a PTSD treatment - Maryland Daily Record
The Daily Record· 2 hours agoA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was...
PTSD Treatments Are Falling Short for Many Patients
New York Times· 24 hours agoThe treatments for PTSD — including several forms of psychotherapy and medication — are effective for many patients, but they don’t work for everyone. “...
Lykos' MDMA treatment rejected by FDA committee, despite being '75% of the way there'
FierceBiotech· 2 hours agoLykos Therapeutics’ attempt to get the first ever MDMA treatment approved in post-traumatic stress...
FDA panel rejects MDMA-based treatment for PTSD
The Hill· 14 hours agoThe Food and Drug Administration (FDA) panel voted 10-1 against endorsing the safety of MDMA in treating PTSD, and 9-2 against its efficacy. The FDA is...
Service dogs ease PTSD symptoms in U.S. military veterans, researchers say
CBS News· 2 hours agoSpecially trained service dogs helped ease PTSD symptoms in U.S. military veterans in a small study...
FDA advisers vote against recommending approval of MDMA as treatment for PTSD
ABC News· 19 hours agoA panel of independent advisers for the U.S. Food and Drug Administration voted against recommending...
MDMA-Maker Failed Its FDA Hearing — And Its PTSD Patients
Bloomberg· 36 minutes agoLykos Therapeutics showed up to a regulatory hearing woefully unprepared. Lisa Jarvis is a Bloomberg...
Psychedelic stocks tanked after FDA committee punted MDMA-assisted therapy for PTSD
Quartz· 2 hours agoFood and Drug Administration (FDA) advisory committee decided not recommend the use of MDMA as a ...
Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment By...
Investing.com· 4 hours agoThe panel voted 10-to-1 against the first MDMA-based PTSD treatment as it is felt that the benefits...
MDMA therapy wait goes on as FDA panel rejects Lykos’ PTSD treatment
Pharmaceutical Technology via Yahoo Finance· 6 hours agoThe two companies will pursue neuroplastogens – agents that induce rapid and long-lasting...